This is the authors' abstract. We don't add key points for this paper.
Sleep disturbance has a prevalence of 30-78% in patients with advanced cancer. While pharmacotherapy is common, randomized controlled studies (RCTs) investigating available agents are limited. This study examines the efficacy and safety of temazepam or melatonin versus placebo for sleep in advanced cancer.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Mendis et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: